SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Schedule Of Net Sales And Operating Income By Reportable Segment

Net sales and profit by reportable segment for the year ended December 31, 2012, 2011 and 2010 are as follows:

	Years Ended December 31,
	2012			2011			2010
	(In thousands)
Segment Net Sales
U.S. Neurosurgery	$	171,278		$	165,652		$	165,606
U.S. Instruments	162,323			155,833			157,853
U.S. Extremities	122,847			98,109			89,529
U.S. Spine and Other	190,546			174,479			152,274
International	183,877			186,005			166,806
Total revenues	$	830,871		$	780,078		$	732,068
Segment Profit
U.S. Neurosurgery	$	91,070		$	86,206		$	83,804
U.S. Instruments	36,550			29,753			27,350
U.S. Extremities	49,432			38,540			39,347
U.S. Spine and Other	55,891			51,011			57,643
International	61,336			64,164			59,636
Segment profit	294,279			269,674			267,780
Amortization	(18,536)			(16,433)			(12,017)
Corporate and other	(201,961		)	(198,329		)	(157,069		)
Operating income	$	73,782		$	54,912		$	98,694

Revenues By Market Category

Revenue by major product category consisted of the following:

	Years Ended December 31,
	2012		2011		2010
	(In thousands)
Orthopedics	$	369,312	$	328,933	$	290,274
Neurosurgery	277,527		272,538		263,147
Instruments	184,032		178,607		178,647
Total Revenues	$	830,871	$	780,078	$	732,068

Total Revenue By Major Geographic Area

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

	United States*		Europe		Rest of the World		Consolidated
	(In thousands)
Total revenue, net:
2012	$	642,830	$	90,920	$	97,121	$	830,871
2011	589,946		97,184		92,948		780,078
2010	561,307		89,044		81,717		732,068
Total long-lived assets:
2012	$	166,508	$	20,242	$	1,507	$	188,257
2011	125,880		17,274		1,357		144,511

* Includes long-lived assets in Puerto Rico.